ARTIOS PHARMA

Artios is an independent DNA Damage Response (DDR) company focused on developing first-in-class treatments for cancer. Established in May 2016, the Company is led by an experienced scientific and leadership team with proven expertise in DDR drug discovery. Artios is building a pipeline of next-generation DDR programs, including through a unique partnership with Cancer Research Technology (CRT), the development and commercialization arm of Cancer Research UK (CRUK), and with leading DNA repair researchers worldwide. The Company’s investors include SV Life Sciences, Merck Ventures, Imperial Innovations, Arix Bioscience PLC, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures. Artios is based at the Babraham Institute in Cambridge, UK.

#SimilarOrganizations #People #Financial #Website #More

ARTIOS PHARMA

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biopharma Biotechnology Medical Device

Founded:

2016-01-01

Address:

Cambridge, Cambridgeshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.artiospharma.com

Total Employee:

101+

Status:

Active

Contact:

+4401223804180

Email Addresses:

[email protected]

Total Funding:

298.28 M USD

Technology used in webpage:

SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS YouTube Amazon London Region

Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

Current Advisors List

rené-kuijten_image

René Kuijten Board Of Director @ Artios Pharma
Board_member

michelle-doig_image

Michelle Doig Board Member @ Artios Pharma
Board_member

not_available_image

Florian Muellershausen Baord Of Observer @ Artios Pharma
Board_member

hamish-cameron_image

Hamish Cameron Chairman of Board @ Artios Pharma
Board_member

hakan-goker_image

Hakan Goker Board Member @ Artios Pharma
Board_member

chen-yu_image

Chen Yu Board Member @ Artios Pharma
Board_member

raphaël-wisniewski_image

Raphaël Wisniewski Board Of Director @ Artios Pharma
Board_member

Current Employees Featured

andrew-muncey_image

Andrew Muncey
Andrew Muncey COO @ Artios Pharma
COO
2021-01-01

peter-harris_image

Peter Harris
Peter Harris Development Consultant @ Artios Pharma
Development Consultant
2019-01-01

graeme-smith_image

Graeme Smith
Graeme Smith Chief Scientific Officer @ Artios Pharma
Chief Scientific Officer

hakan-goker_image

Hakan Goker
Hakan Goker Board Member @ Artios Pharma
Board Member
2016-09-01

not_available_image

Kirsty Mackay
Kirsty Mackay Director of Clinical Development @ Artios Pharma
Director of Clinical Development
2021-01-01

abid-ansari_image

Abid Ansari
Abid Ansari Chief Financial Officer @ Artios Pharma
Chief Financial Officer
2021-01-01

niall-martin_image

Niall Martin
Niall Martin Chief Executive Officer @ Artios Pharma
Chief Executive Officer
2016-09-01

Founder

andrew-muncey_image

Andrew Muncey

Investors List

avidity-partners_image

Avidity Partners

Avidity Partners investment in Series C - Artios Pharma

edmond-de-rothschild-investment-partners_image

Andera Partners

Andera Partners investment in Series C - Artios Pharma

merckventures_image

M Ventures

M Ventures investment in Series C - Artios Pharma

tetragon-financial-group-limited_image

Tetragon Financial Group Limited

Tetragon Financial Group Limited investment in Series C - Artios Pharma

soleus-capital_image

Soleus Capital

Soleus Capital investment in Series C - Artios Pharma

arix-bioscience_image

Arix Bioscience

Arix Bioscience investment in Series C - Artios Pharma

rtw-investments-llc_image

RTW Investments LLC

RTW Investments LLC investment in Series C - Artios Pharma

piper-sandler_image

Piper Sandler

Piper Sandler investment in Series C - Artios Pharma

caas-capital-management_image

CaaS Capital Management

CaaS Capital Management investment in Series C - Artios Pharma

deep-track-capital_image

Deep Track Capital

Deep Track Capital investment in Series C - Artios Pharma

Official Site Inspections

http://www.artiospharma.com

Host Informations
Whois Informations

Loading ...

More informations about "Artios Pharma" on Search Engine